Literature DB >> 21111762

Calpain digestion and HSP90-based chaperone protection modulate the level of plasma membrane F508del-CFTR.

Monica Averna1, Roberto Stifanese, Raffaella Grosso, Marco Pedrazzi, Roberta De Tullio, Franca Salamino, Bianca Sparatore, Sandro Pontremoli, Edon Melloni.   

Abstract

We are here showing that peripheral mononuclear blood cells (PBMC) from cystic fibrosis (CF) patients contain almost undetectable amounts of mature 170 kDa CF-transmembrane conductance regulator (CFTR) and a highly represented 100 kDa form. This CFTR protein, resembling the form produced by calpain digestion and present, although in lower amounts, also in normal PBMC, is localized in cytoplasmic internal vesicles. These observations are thus revealing that the calpain-mediated proteolysis is largely increased in cells from CF patients. To characterize the process leading to the accumulation of such split CFTR, FRT cells expressing the F508del-CFTR mutated channel protein and human leukaemic T cell line (JA3), expressing wild type CFTR were used. In in vitro experiments, the sensitivity of the mutated channel to the protease is identical to that of the wild type, whereas in Ca(2+)-loaded cells F508del-CFTR is more susceptible to digestion. Inhibition of intracellular calpain activity prevents CFTR degradation and leads to a 10-fold increase in the level of F508del-CFTR at the plasma membrane, further indicating the involvement of calpain activity in the maintenance of very low levels of mature channel form. The higher sensitivity to calpain of the mutated 170 kDa CFTR results from a reduced affinity for HSP90 causing a lower degree of protection from calpain digestion. The recovery of HSP90 binding capacity in F508del-CFTR, following digestion, explains the large accumulation of the 100 kDa CFTR form in circulating PBMC from CF patients. Copyright Â
© 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21111762     DOI: 10.1016/j.bbamcr.2010.11.008

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  5 in total

1.  Inflammasome-mediated IL-1β production in humans with cystic fibrosis.

Authors:  Anthony Tang; Ashish Sharma; Roger Jen; Aaron F Hirschfeld; Mark A Chilvers; Pascal M Lavoie; Stuart E Turvey
Journal:  PLoS One       Date:  2012-05-23       Impact factor: 3.240

2.  Interaction between calpain-1 and HSP90: new insights into the regulation of localization and activity of the protease.

Authors:  Monica Averna; Roberta De Tullio; Marco Pedrazzi; Margherita Bavestrello; Matteo Pellegrini; Franca Salamino; Sandro Pontremoli; Edon Melloni
Journal:  PLoS One       Date:  2015-01-09       Impact factor: 3.240

3.  Calpain inhibition promotes the rescue of F(508)del-CFTR in PBMC from cystic fibrosis patients.

Authors:  Monica Averna; Marco Pedrazzi; Laura Minicucci; Roberta De Tullio; Federico Cresta; Franca Salamino; Sandro Pontremoli; Edon Melloni
Journal:  PLoS One       Date:  2013-06-13       Impact factor: 3.240

4.  The mitochondrial complex I activity is reduced in cells with impaired cystic fibrosis transmembrane conductance regulator (CFTR) function.

Authors:  Angel G Valdivieso; Mariángeles Clauzure; María C Marín; Guillermo L Taminelli; María M Massip Copiz; Francisco Sánchez; Gustavo Schulman; María L Teiber; Tomás A Santa-Coloma
Journal:  PLoS One       Date:  2012-11-21       Impact factor: 3.240

5.  CFTR mutations altering CFTR fragmentation.

Authors:  Kendra Tosoni; Michelle Stobbart; Diane M Cassidy; Andrea Venerando; Mario A Pagano; Simão Luz; Margarida D Amaral; Karl Kunzelmann; Lorenzo A Pinna; Carlos M Farinha; Anil Mehta
Journal:  Biochem J       Date:  2013-01-01       Impact factor: 3.857

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.